How SGS supports Cell and Gene Therapy Manufacturing
The Cell and Gene Therapy product manufacturing process requires comprehensive testing regimens which must address key aspects of safety, identity, strength/potency, purity and quality.
Achieving these milestones during development often requires support from a trusted outsourcing partner with an exceptional testing portfolio of analytical services and expertise found within the key biopharmaceutical pillars of biosafety, characterization and QC & release.
Download this new infographic to learn how you can address the rigorous demands of these analytical requirements, including development (de novo), transfer, stability and release for your cell or gene therapy product.
Offered Free by: SGS North America
See All Resources from: SGS North America